The concentration of ACE2 was found significantly higher in diabetic patients at CKD stage 4 (defined as eGFR = 30 mL/min/1.73m2), suggesting a possible role in the staging of chronic diabetic kidney disease (19). Here, ACE2 is linked to chronic kidney disease.